Latest News
Group behind one of biggest Canadian biotech takeovers unveils latest addition to Vancouver’s teeming life sciences sector
Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
New treatments will step in to replace blockbuster eye medication EYLEA.
Judicial Panel Rejects Bayer Monsanto Attempt to Thwart Fair Settlement for Roundup-Cancer Victims
/PRNewswire/ -- A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits...